Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years

PARSIPPANY, N.J., June 5, 2000 -- Aventis Pharmaceuticals announced today that Allegra® (fexofenadine HCl) 30-mg tablets, twice daily (BID), are now available by prescription for the relief of seasonal allergic rhinitis (SAR) and chronic idiopathic urticaria (CIU) in children aged 6 to 11 years.

"Seasonal allergies affect up to six million children in the United States," said Eli Meltzer, M.D., of the Allergy and Asthma Group and Research Center, San Diego, California and lead investigator of the clinical study, Safety of Fexofenadine HCl in Children Treated for Seasonal Allergic Rhinitis. "Allegra 30-mg tablets offer physicians a safe, nonsedating allergy treatment that can help in the management of children's seasonal allergies."

In a study of 411 pediatric patients, Allegra 30-mg tablets BID significantly reduced total symptom scores compared to placebo and was well tolerated among children aged 6 to 11 years. Such allergy symptoms, including runny nose, itchy, watery, red eyes, sneezing and itchy nose, palate and throat can hinder the enjoyment of outdoor activities that children like to pursue.

Allegra 30-mg tablets are nonchewable and are smaller than a chocolate chip. This pediatric dose is an addition to the Allegra family of products currently available for patients 12 and older, including Allegra® (fexofenadine HCl) 60-mg capsules, Allegra-D® (fexofenadine HCl 60 mg/pseudoephedrine HCl 120 mg) Extended-Release Tablets and Allegra® (fexofenadine HCl) 180-mg tablets.

Side-Effect Profile
In clinical trials, adverse events with Allegra 30-mg tablets were similar to placebo. The most commonly reported with Allegra 30-mg tablets and placebo in seasonal allergic rhinitis patients 6-11 years are headache (7.2% vs. 6.6%), upper respiratory tract infection (4.3% vs. 1.7%), coughing (3.8% vs. 1.3%), and accidental injury (2.9% vs. 1.3%).

Allegra 60-mg capsules are well tolerated with side effects similar to placebo.

Contact: Charles F. Rouse III
Porter Novelli

Page: 1 2 3

Related medicine news :

1. Aventis Pasteur ready to meet nations needs for tetanus and diphtheria vaccine
2. Aventis Pasteur donates approximately 75 to 90 million doses of smallpox vaccine to the U.S.
3. Aventis Pasteur statement on HVTN 501 decision
4. Millennium, Aventis Pharma form novel alliance
5. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
6. MetaPhore Pharmaceuticals initiates Phase I clinical trial of enzyme mimetic compound for oncology
7. Maret Pharmaceuticals presents promising Phase I/II clinical MARstem™ results at international symposium on new drugs in cancer therapy
8. NIH awards grant to MetaPhore Pharmaceuticals to study novel pain treatments
9. Pharmaceuticals and personal care products
10. Nortran Pharmaceuticals Inc. and Hoechst Marion Roussel announce collaborativeagreement
11. Signal Pharmaceuticals Announces Positive Results In Preclinical Study Of Novel Drug Leads For Treatment Of Osteoporosis

Post Your Comments:

(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
Cached News: